Navigation Links
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Date:5/20/2013

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
2. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
3. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
4. Valeant Pharmaceuticals Provides Efinconazole Update
5. Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
7. Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
8. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
9. Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
10. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
11. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2019)... (PRWEB) , ... October 14, 2019 , ... An October ... the mounting evidence suggesting a correlation between tooth loss and heart disease. The researchers ... had a 28 percent chance of also having heart-related problems, compared to just seven ...
(Date:10/11/2019)... ... October 11, 2019 , ... American Case Management Association (ACMA) ... dedication, compassion and quality patient outcomes achieved by case management professionals across the ... link between patients, providers and payers to improve health outcomes across the care ...
(Date:10/11/2019)... , ... October 11, 2019 , ... MindShare Technology Founder ... outcomes at the 2019 Alliance for Strong Families and Communities National Conference. The conference ... October 16, 2019 from 3:30 – 5:00 p.m. , Povolny’s presentation will provide ...
Breaking Medicine Technology:
(Date:10/11/2019)... ... October 11, 2019 , ... A Topping Out event was ... facility by general contractors Adolfson & Peterson Construction. The event celebrated reaching the final ... Midtown Road in Dallas. The first of its kind in Texas, STA’s facility will ...
(Date:10/10/2019)... ... October 10, 2019 , ... ... Nutrition 21 was excited to hear the significant results of an independent study ... impact of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... recently acquired a majority interest in Advanced Fertility Care (AFC), an advanced reproductive ... joining forces to expand the availability of RE services to expectant families throughout ...
(Date:10/8/2019)... Md. (PRWEB) , ... October 08, 2019 , ... ... fungal infection progression in live samples, Meiqing Shi, associate professor with the University ... field. In his latest paper published in Nature Communications, Shi and his lab ...
(Date:10/8/2019)... Md. (PRWEB) , ... October 08, 2019 , ... METAvivor ... metastatic breast cancer, announced the launch of its Stage IV Stampede campaign. The campaign ... 2019 in Washington, DC that will include an advocacy boot camp, a march, a ...
Breaking Medicine News(10 mins):